These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16566383)

  • 21. [Macroprolactinemia. Risk of misdiagnosis and mismanagement in hyperprolactinemia].
    Valdemarsson S
    Lakartidningen; 2004 Feb; 101(6):458-65. PubMed ID: 15004940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
    Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
    Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
    Holt RI
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyperprolactinemia: causes, diagnosis, and treatment].
    Karasek M; Pawlikowski M; Lewiński A
    Endokrynol Pol; 2006; 57(6):656-62. PubMed ID: 17253440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolactin in men's health and disease.
    Bolyakov A; Paduch DA
    Curr Opin Urol; 2011 Nov; 21(6):527-34. PubMed ID: 21941183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical inquiries. What is the recommended evaluation and treatment for elevated serum prolactin?
    Jackson J; Safranek S; Daugird A
    J Fam Pract; 2005 Oct; 54(10):897-8, 901. PubMed ID: 16202380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperprolactinaemia--pitfalls in PRL assessment].
    Zgliczyński W; Zdunowski P
    Endokrynol Pol; 2005; 56(6):980-5. PubMed ID: 16821223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and diagnostic characteristics of hyperprolactinemia in childhood and adolescence.
    Catli G; Abaci A; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2013; 26(1-2):1-11. PubMed ID: 23327784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The diagnosis and therapy of hyperprolactinemia].
    Falaschi P; Pajalich R; Ruotolo G; Pastore R; Martocchia A; Di Biasi C; Trasimeni G; Gualdi G; Balsano F
    Recenti Prog Med; 1993 Apr; 84(4):296-310. PubMed ID: 8488335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macroprolactin: From laboratory to clinical practice.
    Biagetti B; Ferrer Costa R; Alfayate Guerra R; Álvarez García E; Berlanga Escalera E; Casals G; Esteban Salán M; Granada Ibern ML; Gorrín Ramos J; López Lazareno N; Oriola J; Sánchez Martínez PM; Torregrosa Quesada ME; Urgell Rull E; García Lacalle C
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Jan; 69(1):63-69. PubMed ID: 35232561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperprolactinemia].
    König MP; Kopp P
    Schweiz Med Wochenschr; 1986 Mar; 116(9):265-70. PubMed ID: 3952483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of macroprolactin.
    Gibney J; Smith TP; McKenna TJ
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):633-43. PubMed ID: 15943822
    [No Abstract]   [Full Text] [Related]  

  • 36. Approach to the patient with persistent hyperprolactinemia and negative sellar imaging.
    Glezer A; Bronstein MD
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2211-6. PubMed ID: 22774208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient guide to hyperprolactinemia diagnosis and treatment.
    Hoffman AR; Melmed S; Schlechte J
    J Clin Endocrinol Metab; 2011 Feb; 96(2):35A-6A. PubMed ID: 21296988
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Proceedings of seminar on hyperprolactinemia and dysfunctional uterine bleeding].
    Yu Q; Zhen JR; Chen GA
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):244-6. PubMed ID: 18843960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.